GOP Senators Demand FDA Explain Hydroxychloroquine Stance Amid Positive Studies And Physician Advocates

Share:

The debate over hydroxychloroquine has faded from the forefront as big tech has worked to suppress information and silence the voices of doctors and researchers promoting it. However, it appears the controversy over the drug has encouraged some senators to take a closer look, and it seems they are asking the FDA the right questions.

Senators Ron Johnson (R-Wis.), Ted Cruz (R-Texas), and Mike Lee (R-Utah) sent a letter to FDA Commissioner Stephen Hahn explicitly asking about the agency’s handling of information regarding the drug and its use during the pandemic.

Doctors and researchers advocating for hydroxychloroquine are recommending it be used in high-risk outpatients.

Texas Congressman Louis Hohmert, who was recently diagnosed positive for COVID-19, tweeted just this morning about the benefits of hydroxychloroquine:

Hydroxychloroquine protocols worked for me. Americans suffering from the Wuhan Virus deserve the right to consult with their doctors and try HCQ if deemed a safe and appropriate fit. Keep Big Govt out of this. Thank you Dr. Risch for your work and research on this.

In the letter to Hahn, the senators are asking about specific actions the agency has taken regarding hydroxychloroquine. The current FDA guidance is that it should not be used outside the hospital setting for COVID-19, and the Emergency Use Authorization (EUA) has been withdrawn. Given the safety profile of the medication and the fact it is used daily on an outpatient basis around the world for malaria prevention, malaria treatment, rheumatoid arthritis, and lupus, this guidance is ridiculous on its face. – READ MORE

Listen to the insightful Thomas Paine Podcast Below --

Share:
No Comments Yet

Leave a Reply

2021 © True Pundit. All rights reserved.